[Result of studies of immunotherapy of lepromatous leprosy and borderline leprosy].
D001500:BCG Vaccine / Q000627:therapeutic use; D003538:Cystamine / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D007918:Leprosy / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D007978:Levamisole / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D001500:BCG Vaccine; D007978:Levamisole; D003538:Cystamine; D012293:Rifampin
Bilan des travaux sur l'immunothérapie dans le lèpre lépromateuse et borderline lépromateuse.